ABSI Q1 | (N=153) | ABSI Q2 | (N=151) | ABSI Q3 | (N=151) | ABSI Q4 | (N=152) | p Value* | |
---|---|---|---|---|---|---|---|---|---|
Mean | (SD) | Mean | (SD) | Mean | (SD) | Mean | (SD) | ||
Age (years) | 59 | (13) | 63 | (11) | 65 | (12) | 69 | (12) | <0.001 |
Gender (% male) | 62 | 70 | 62 | 45 | 0.001 | ||||
SBP (mm Hg) | 129 | (19) | 132 | (18) | 128 | (17) | 131 | (20) | 0.216 |
DBP (mm Hg) | 76 | (12) | 77 | (13) | 76 | (11) | 74 | (12) | 0.403 |
HbA1c (mmol/L) | 72.8 | (21.4) | 72.2 | (19.3) | 76.0 | (19.4) | 72.1 | (19.5) | 0.410 |
HbA1c (%) | 8.8 | (2.0) | 8.7 | (1.8) | 9.0 | (2.0) | 8.8 | (1.9) | |
HDL-C (mmol/L) | 1.25 | (0.41) | 1.24 | (0.33) | 1.23 | (0.39) | 1.31 | (0.34) | 0.252 |
LDL-C (mmol/L) | 2.91 | (0.91) | 3.03 | (1.02) | 2.82 | (0.78) | 2.94 | (0.86) | 0.238 |
Triglycerides (mmol/L) | 1.45 | (1.10 to 1.81) | 1.47 | (1.16 to 1.77) | 1.51 | (1.08 to 1.99) | 1.45 | (1.32 to 1.56) | 0.613 |
Urinary C peptide (μg/day) | 47.1 | (42.9 to 51.4) | 48.4 | (44.7 to 52.0) | 45.8 | (41.6 to 50.0) | 33.9 | (30.8 to 37.0) | 0.001 |
DM duration (years) | 12 | (10) | 12 | (10) | 12 | (9) | 15 | (10) | 0.044 |
Urinary albumin (mg/day) | 28.5 | (15 to 42) | 27.7 | (19 to 37) | 17.6 | (16 to 19) | 20.9 | (12 to 30) | 0.014 |
eGFR (mL/min/1.73 m2) | 73.6 | (24.8) | 72.0 | (24.5) | 70.4 | (23.8) | 70.9 | (28.9) | 0.691 |
PDR (%) | 12 | 12 | 14 | 15 | 0.726 | ||||
CV-RR (%) | 4.3 | (2.4) | 4.2 | (2.3) | 3.8 | (2.3) | 3.3 | (2.0) | 0.003 |
baPWV (cm/s) | 1611 | (349) | 1702 | (520) | 1713 | (356) | 1806 | (393) | 0.001 |
History of CVD (%) | 14 | 14 | 15 | 16 | 0.946 |
Data are expressed as mean (SD), geometric mean (95% CI) or percentage as appropriate.
*ANOVA or χ2 test.
ABSI, A Body Shape Index; ANOVA, analysis of variance; baPWV, brachial-ankle pulse wave velocity; CVD, cardiovascular disease; CV-RR, coefficient of variation of R-R intervals; DBP, diastolic blood pressure; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; PDR, proliferative diabetic retinopathy; SBP, systolic blood pressure.